Janet Dancey
Queens University
H-index: 86
Asia-Bangladesh
Top articles of Janet Dancey
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Accrual of adolescents and young adults (AYA) into cancer clinical trials in Canada. | Mariam Jafri Corey Willman Alison May Urton Jan-Willem Henning Lesleigh S Abbott | 2023/6/1 | |
Abstract CT212: A ctDNA-directed, multi-center phase II study of molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer: Analysis of Stage … | Cancer Research | Valsamo K Anagnostou Cheryl Ho Garth Nicholas Rosalyn Anne Juergens Adrian Sacher | 2023/4/14 |
Minding the gaps: assessing and addressing clinical research core competencies across a network of Canadian cancer centres | Frontiers in Pharmacology | Stephen Sundquist Diana Kato Raisa Chowdhury Christine Samara Janet E Dancey | 2023/12/8 |
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results | Nature medicine | Valsamo Anagnostou Cheryl Ho Garth Nicholas Rosalyn Anne Juergens Adrian Sacher | 2023/10 |
CRI-CCTG-0003/IND. 240: An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC). | Helen Mackay Anna Tinker Brad Nelson Dmitriy Zamarin Kunle Odunsi | 2023/6/1 | |
Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator: A Cross-Sectional Analysis | Cancer Control | Caroline Hamm Dora Cavallo-Medved Devinder Moudgil Lee McGrath John Huang | 2022/9/22 |
The impact of COVID-19 on academic cancer clinical trials in Canada and the initial response from cancer centers | Current Oncology | Stephen Sundquist Diana Kato Rebecca Y Xu James Schoales Saranya Kulendran | 2022/3/30 |
CCTG BR34: A randomized phase 2 trial of durvalumab and tremelimumab with or without platinum-based chemotherapy in patients with metastatic NSCLC | Journal of Thoracic Oncology | Natasha B Leighl Scott A Laurie Glenwood D Goss Brett GM Hughes Martin Stockler | 2022/3/1 |
EML4-ALK Fusion Gene and Therapy with ALK-Targeted Agents in Non-Small Cell Lung Cancer | Francisco E Vera-Badillo Janet E Dancey | 2021/1/31 | |
FP05. 02 a Biomarker-Directed, multi-center phase II study of molecular response adaptive Immuno-Chemotherapy in lung cancer | Journal of Thoracic Oncology | V Anagnostou C Ho P Wheatley-Price S Laurie J Taylor | 2021/10/1 |
Biomarkers for the Management of Malignancies with BRAF Mutation | Janet E Dancey | 2021/1/31 | |
CRAFT—a proposed framework for decentralized clinical trials participation in Canada | Stephen Sundquist Gerald Batist Kathy Brodeur-Robb Kathryn Dyck Bernhard J Eigl | 2021/9/30 | |
Markers of Sensitivity and Resistance to EGFR Inhibitors in Colorectal Cancer | Jose G Monzon Janet E Dancey | 2021/1/31 | |
Advancing academic cancer clinical trials recruitment in Canada | Rebecca Y Xu Diana Kato Gregory R Pond Stephen Sundquist James Schoales | 2021/7/28 | |
Neuro-Oncology Advances | Masafumi Miyai Tomohiro Kanayama Fuminori Hyodo Takamasa Kinoshita Takuma Ishihara | 2020 | |
Handbook of Therapeutic Biomarkers in Cancer | Sherry X Yang Janet E Dancey | 2021/2/1 | |
Predictive Biomarkers for Epidermal Growth Factor Receptor Agents in Non-Small Cell Lung Cancer | Penelope Bradbury John Hilton Janet E Dancey | 2021/1/31 | |
CCTG BR. 34: A randomized trial of durvalumab and tremelimumab+/-platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung … | Natasha B Leighl Scott Andrew Laurie Glenwood D Goss Brett Gordon Maxwell Hughes Martin R Stockler | 2020/5/20 | |
Clinical trials navigator: Patient-centered access to clinical trials. | Caroline M Hamm Krista Naccarato Stephen Sundquist Suzana Kovacevic Youshaa El-Abed | 2020/5/20 | |
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms | Begona de las Heras Ruth Plummer Victor Moreno Marco Romano Javier Mayor de Castro | 2020/9/8 |
